Role of Nrf2 in Parkinson’s Disease: Toward New Perspectives
Parkinson’s disease (PD) is one of the most common and chronic degenerative diseases in the central nervous system. The main pathology of PD formation is the progressive loss of dopaminergic neurons in substantia nigra and the formation of α-synuclein-rich Lewy bodies. The pathogenesis of PD is not...
Main Authors: | Xin-xing Yang, Rong Yang, Feng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.919233/full |
Similar Items
-
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
by: Yumin Wang, et al.
Published: (2021-11-01) -
Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
by: Francisca Villavicencio Tejo, et al.
Published: (2021-07-01) -
The Differentially Expressed Circular RNAs in the Substantia Nigra and Corpus Striatum of Nrf2-Knockout Mice
by: Jun-Hui Yang, et al.
Published: (2018-10-01) -
α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
by: Alberto Delaidelli, et al.
Published: (2021-06-01) -
Astrocytic Nrf2 Mediates the Neuroprotective and Anti-Inflammatory Effects of Nootkatone in an MPTP-Induced Parkinson’s Disease Mouse Model
by: Jung-Eun Park, et al.
Published: (2023-11-01)